세계의 감염 관리 시장 보고서(2025년)
Infection Control Global Market Report 2025
상품코드 : 1824287
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

감염 관리 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 1,798억 8,000만 달러로 성장하며, CAGR은 7.6%를 나타낼 전망입니다. 예측 기간의 성장은 유행에 대비하고, 건강 관리 인프라의 성장, 항균제 내성 증가, 규제 상황의 진화, 공중 보건 활동에 기인합니다. 예측 기간의 주요 동향으로는 헬스케어의 기술통합, 감염관리제품의 기술 혁신, 소독에 있어서의 기술진보, 손지위생중시의 고조, 신속한 멸균기술 등이 있습니다.

향후 5년간의 성장률 7.6%라고 하는 예측은 전회 예측으로부터 0.2%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세 장벽은 핀란드와 이스라엘에서 조달하는 항균 표면 코팅제와 UV 살균 시스템의 비용을 상승시키고, 살균 프로토콜을 손상시키고 병원의 운영 비용을 상승시킴으로써 미국에 지장을 초래할 것으로 예측됩니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.

감염 관리 시장 성장은 원내 감염 증가에 의해 촉진될 것으로 예측됩니다. 병원 감염(건강 관련 감염이라고도 함)은 헬스 케어 시설 내에서 환자가 감염하는 것입니다. 이러한 감염에는 중심 정맥 카테터와 관련된 혈류 감염 및 요로 감염과 같은 질병이 포함됩니다. 감염 관리는 고급 서비스, 위생 및 멸균 실천을 통해 의료 현장에서 감염의 전파를 예방하는 중요한 역할을 담당합니다. 이러한 감염 관리 대책이 쉽다는 것이 시장 성장에 기여합니다. 2022년 5월 기준 세계보건기구(WHO)는 전 세계 환자의 24% 이상이 의료 관련 감염의 영향을 받고 있다고 보고했습니다. 게다가 미국 질병대책예방센터(CDC)의 추계에 따르면 2022년까지 연간 약 170만 건의 원내 감염과 9만 9,000건의 관련 사망이 발생했으며, 앞으로도 증가할 것으로 예측되고 있습니다. 따라서 원내감염의 발생률 상승은 감염 관리 시장 성장 촉진요인이 되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

Infection control is the practice of preventing or halting the spread of illnesses in healthcare settings and other environments where the risk of infection is high. It aims to provide a high level of protection for patients, medical personnel, and others in healthcare settings, ultimately preventing the transmission of communicable diseases.

The main types of products and services used in infection control include disinfectors, sterilization equipment, consumables and accessories, and various services. Disinfectors encompass the company's endoscope disinfector products and standard accessories as a whole. These products are distributed through methods such as direct tenders, retail sales, and third-party distributors. They find applications in various areas, including the disinfection of surgical instruments, endoscopes, ultrasound probes, and other related applications. Major end-users of infection control products and services include hospitals and clinics, medical device companies, pharmaceutical companies, the life sciences industry, the food industry, and other relevant sectors.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The infection control market research report is one of a series of new reports from The Business Research Company that provides infection control market statistics, including infection control industry global market size, regional shares, competitors with a infection control market share, detailed infection control market segments, market trends and opportunities, and any further data you may need to thrive in the infection control industry. This infection control market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The infection control market size has grown strongly in recent years. It will grow from $127.09 billion in 2024 to $134.38 billion in 2025 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to healthcare-associated infections (HAIs), stringent regulatory standards, rising awareness of infectious diseases, globalization and travel, increased healthcare expenditure.

The infection control market size is expected to see strong growth in the next few years. It will grow to $179.88 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to pandemic preparedness, growing healthcare infrastructure, rising antimicrobial resistance, evolving regulatory landscape, public health initiatives. Major trends in the forecast period include technological integration in healthcare, technological innovations in infection control products, technological advancements in disinfection, increased emphasis on hand hygiene, rapid sterilization techniques.

The forecast of 7.6% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S.by increasing the cost of antimicrobial surface coatings and UV disinfection systems sourced from Finland and Israel, thereby compromising sterilization protocols and elevating hospital operational costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth of the infection control market is expected to be propelled by the increasing incidence of hospital-acquired infections. Hospital-acquired infections, also known as healthcare-associated infections, are contracted by patients within healthcare facilities. These infections include conditions such as bloodstream infections and urinary tract infections linked to central-line catheters. Infection control plays a crucial role in preventing the transmission of communicable diseases in healthcare settings through high-level services, hygiene, and sterilization practices. The ease of these infection control measures contributes to the market's growth. As of May 2022, the World Health Organization reported that over 24% of patients worldwide were affected by healthcare-associated infections. Additionally, estimates from the Centers for Disease Control and Prevention (CDC) in the US indicated that hospital-acquired infections accounted for around 1.7 million infections and 99,000 associated deaths annually by 2022, with a projected increase in the future. Thus, the rising incidence of hospital-acquired infections is a driving factor for the infection control market.

The rise in surgical procedures is expected to propel the growth of the infection control market in the coming years. A surgical procedure refers to a medical intervention or operation carried out by a qualified surgeon or medical professional to treat a disease, address a health issue, or repair a bodily structure. As the number of surgical procedures increases, there is a greater demand for effective sterilization and disinfection practices for surgical instruments, equipment, and operating rooms, thereby promoting the adoption of infection control products and services. For example, in August 2023, The Aesthetic Society, a U.S.-based organization focused on plastic surgery and cosmetic medicine, reported that Americans spent over $11.8 billion on aesthetic procedures, marking a 2% increase from the previous year. Thus, the growing number of surgical procedures is driving the expansion of the infection control market.

Major companies in the infection control market are focusing on developing intuitive user interface designs, enabling healthcare professionals to easily access tools for monitoring cleanliness and tracking infection rates, thereby enhancing patient safety and operational efficiency. Intuitive design refers to creating products or interfaces that are user-friendly and straightforward, reducing the need for instructions or prior knowledge. For instance, in January 2024, ICP Medical, a U.S.-based infection prevention company, launched a new website aimed at improving user experience while reflecting its mission of "Helping Those Who Help Others." This updated platform consolidates ICP Medical's infection control products, including Rapid Refresh quick-change privacy curtains and the BootieButler automatic shoe cover system, creating a convenient "one-stop shop" for customers. In line with TEAM Technologies' branding, the website caters to healthcare, industrial, and government sectors, featuring an easy-to-navigate design. Key features include seamless e-commerce capabilities, comprehensive product displays, FAQs, downloadable resources, and engaging instructional videos to streamline the purchasing process. Additionally, a dedicated page for privacy curtain samples showcases various patterns and styles, emphasizing ICP Medical's commitment to accessible and effective infection prevention solutions.

Technological advancements in sterilization equipment are a significant trend in the infection control supplies market. Leading companies in this sector are developing innovative solutions, such as sterilizers, to improve the effectiveness and efficiency of sterilization processes. A sterilizer is a device that eradicates all microbial life on instruments through heat, steam, or chemicals, ensuring they are safe for reuse in medical and dental environments. For example, in January 2024, W&H Dentalwerk Burmoos GmbH, an Austria-based dental technology firm, introduced the Lexa Plus sterilizer as a new innovation in infection control. The Lexa Plus sterilizer is designed to enhance the sterilization process with features such as rapid cycle times, intuitive controls, and advanced monitoring capabilities. This cutting-edge equipment not only guarantees effective sterilization of dental instruments but also includes user-friendly technology that simplifies operation for dental professionals. By improving efficiency and safety, the Lexa Plus aims to address the evolving needs of dental practices while promoting higher standards of infection prevention and patient care.

In December 2022, Paras Healthcare, an India-based healthcare company, formed a partnership with Polymed for an undisclosed amount. This collaboration aims to strengthen their infection control initiatives by incorporating advanced medical technologies and innovative solutions into their healthcare facilities. Polymed, also based in India, specializes in the manufacturing and supply of a diverse range of healthcare products.

Major companies operating in the infection control market include Belimed AG, 3M Company, Ecolab Inc., Advanced Sterilization Products Services Inc., Getinge AB, Matachana Group, Miele Group, Sotera Health Inc., Steris plc., Reckitt Benckiser Group plc., Pal International, Metrex Research LLC, Stryker Corporation, B. Braun Melsungen AG, Olympus Corporation, Fortive Corporation, Cantel Medical Corporation, MELAG Medizintechnik GmbH & Co. KG, The HUBSCRUB Company, Daniels Corporation International Pty. Ltd., Infection Control Consulting Services, Becton Dickinson and Company, Infection Control Results, Sterigenics International LLC, Bioquell Inc., Sterilmed Inc., Conmed Corporation, Johnson & Johnson

North America was the largest region in the infection control market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global infection control market report during the forecast period. The regions covered in the infection control market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the infection control market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The infection control market includes revenues earned by entities by providing services such as environmental infection control, hand hygiene services, isolation precautions, and safe injection practice services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Infection Control Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on infection control market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for infection control ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The infection control market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Infection Control Market Characteristics

3. Infection Control Market Trends And Strategies

4. Infection Control Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Infection Control Growth Analysis And Strategic Analysis Framework

6. Infection Control Market Segmentation

7. Infection Control Market Regional And Country Analysis

8. Asia-Pacific Infection Control Market

9. China Infection Control Market

10. India Infection Control Market

11. Japan Infection Control Market

12. Australia Infection Control Market

13. Indonesia Infection Control Market

14. South Korea Infection Control Market

15. Western Europe Infection Control Market

16. UK Infection Control Market

17. Germany Infection Control Market

18. France Infection Control Market

19. Italy Infection Control Market

20. Spain Infection Control Market

21. Eastern Europe Infection Control Market

22. Russia Infection Control Market

23. North America Infection Control Market

24. USA Infection Control Market

25. Canada Infection Control Market

26. South America Infection Control Market

27. Brazil Infection Control Market

28. Middle East Infection Control Market

29. Africa Infection Control Market

30. Infection Control Market Competitive Landscape And Company Profiles

31. Infection Control Market Other Major And Innovative Companies

32. Global Infection Control Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Infection Control Market

34. Recent Developments In The Infection Control Market

35. Infection Control Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기